Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « D. Hosking »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
D. Hoske < D. Hosking < D. Hossfeld  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
001750 (2008) D. M. Reid [Royaume-Uni] ; D. Hosking [Royaume-Uni] ; D. Kendler [Canada] ; M. L. Brandi [Italie] ; J. D. Wark [Australie] ; J. F. Marques-Neto [Brésil] ; G. Weryha [France] ; N. Verbruggen [États-Unis] ; C. M. Hustad [États-Unis] ; E. M. Mahlis [États-Unis] ; M. E. Melton [États-Unis]A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International
001D58 (1996) J. P. Devogelaer [Belgique] ; H. Broll [Autriche] ; R. Correa-Rotter [Mexique] ; D. C. Cumming [Canada] ; C. Nagant De Deuxchaisnes [Belgique] ; P. Geusens [Belgique] ; D. Hosking [Royaume-Uni] ; P. Jaeger [Suisse] ; J. M. Kaufman [Belgique] ; M. Leite [Brésil] ; J. Leon [Colombie] ; U. Liberman [Israël] ; C. J. Menkes [France] ; P. J. Meunier [France] ; I. Reid [Nouvelle-Zélande] ; J. Rodriguez [Chili] ; A. Romanowicz [Argentine] ; E. Seeman [Australie] ; A. Vermeulen [Belgique] ; L. J. Hirsch [États-Unis] ; A. Lombardi [États-Unis] ; K. Plezia [États-Unis] ; A. C. Santora [États-Unis] ; A. J. Yates [États-Unis] ; W. Yuan [États-Unis]Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Alendronate
2Baseline
2Biochemical markers
2Bone miner
2Bone mineral density
2Bone resorption
2Bone strength
2Bone turnover
2Clin endocrinol metab
2Femoral
2Femoral neck
2Fracture
2Fracture risk
2Lumbar
2Lumbar spine
2Osteoporosis
2Percent change
2Postmenopausal
2Postmenopausal osteoporosis
2Postmenopausal women
2Resorption
2Treatment groups
2Trochanter
2Turnover
1Adult
1Adverse experiences
1Alendronate group
1Alendronate groups
1Alendronate risedronate
1Alendronate treatment
1Alendronic acid
1Antiosteoclastic agent
1Antiosteoporotic
1Antiresorptive
1Antiresorptive agent
1Antiresorptive agents
1April
1Base study
1Baseline month
1Baseline rate
1Biochemical indices
1Blackwell publishing
1Bone density
1Bone formation
1Bone loss
1Bone mass
1Bone turnover markers
1Calcif tissue
1Calcium homeostasis
1Clin
1Clin pract
1Cohort
1Comparative study
1Cortical sites
1Critical revision
1Data collection
1Data interpretation
1Devogelaer
1Dos
1Dpyr
1Extension study
1February
1February devogelaer
1Female
1Fracture intervention trial
1Fracture rates
1Fracture risk reductions
1Greater increases
1International
1Journal compilation
1Lateral spine
1Marker
1Medicine
1Merck
1Miner
1Mineral metabolism
1Month figure
1Nonvertebral fractures
1Open circles
1Percent changes
1Percentage change
1Placebo
1Placebo group
1Postmenopause
1Pract
1Proximal femur
1Result
1Risedronate
1Risedronate treatment
1Risedronic acid
1Safety profile
1Serum calcium
1Significant increases
1Spine
1Study drug
1Study medication
1Surrogate
1Time points
1Tolerability
1Total body

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "D. Hosking" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "D. Hosking" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    D. Hosking
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024